SCHEMBL4456725

SCHEMBL4456725

N/C(=N\O)c1cccnc1.O=C(O)c1cccc(-c2nc(-c3cccnc3)no2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 2/20 0.55
NPC1 O15118 6/20 0.54
RAB9A P51151 5/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
KMO O15229 1/20 0.53
CHRNB2 P17787 4/20 0.52
CHRNA5 P30532 4/20 0.52
CHRNA4 P43681 4/20 0.52
TP53 P04637 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
MAPT P10636 3/20 0.51
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 2/20 0.51
HSD17B10 Q99714 2/20 0.51
HPGD P15428 1/20 0.51
NR1H4 Q96RI1 1/20 0.49
S1PR1 P21453 2/20 0.47
PKM P14618 1/20 0.47
MAOA P21397 1/20 0.47
BLVRB P30043 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4456727 1.00 CA9 (0.55) CA9NPC1RAB9AL3MBTL1KMO
SCHEMBL1422372 0.89 KMO (0.67) CA9NPC1RAB9AL3MBTL1KMO
SCHEMBL60783 0.84 SMN1; SMN2 (0.67) CA9NPC1RAB9AL3MBTL1KMO
SCHEMBL1422760 0.83 CA9 (0.65) CA9NPC1RAB9ACHRNB2CHRNA5
SCHEMBL1422479 0.78 CHRNB2 (0.64) CA9NPC1RAB9ACHRNB2CHRNA5
Niacin SCHEMBL9231503 0.77 ALDH1A1 (0.70) KMOMAPTALDH1A1KDM4EPOLB
SCHEMBL4456732 0.77 CA9 (0.55) CA9NPC1RAB9ACHRNB2CHRNA5
SCHEMBL12171569 0.76 NPC1 (0.76) NPC1RAB9AL3MBTL1KMOTP53
SCHEMBL28784577 0.75 S1PR1 (0.62) CA9NPC1RAB9ACHRNB2CHRNA5
SCHEMBL12171589 0.74 SMN1; SMN2 (0.75) CA9NPC1RAB9ACHRNB2CHRNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101763-A2 PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE Abbott Laboratories (US) 2009-09-23 EP disclosed
WO-2008073942-A2 PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-06-19 WO disclosed